| Dr Zuie Wakade, | |
|
900 Rand Rd Ste 120, Des Plaines, IL 60016-2359 | |
| (312) 767-3244 | |
| Not Available |
| Full Name | Dr Zuie Wakade |
|---|---|
| Gender | Female |
| Speciality | Gastroenterology |
| Experience | 12 Years |
| Location | 900 Rand Rd Ste 120, Des Plaines, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013273150 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 036146543 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Loyola University Medical Center | Maywood, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Loyola University Medical Center | 3779488903 | 863 |
| Midwest Digestive Health And Nutrition, Pllc | 2769830389 | 16 |
News Archive
The discovery that a protein called Rictor plays a key role in destroying a close cousin of the AKT oncogene could provide scientists with a new molecular target for treating certain cancers, including breast cancer. Described in the September 2010 issue of the journal Molecular Cell, the study was led by scientists at Beth Israel Deaconess Medical Center (BIDMC).
A researcher from the Center for BrainHealth at UT Dallas has been awarded a $2.7 million grant from the Department of Defense under the Joint Warfighter Medical Research Program.
DSM, a global leader in biomedical materials sciences, today announced that it is contributing proprietary knowledge in the preparation of tailored amino acid-based polymers and offering use of processing facilities that will produce an innovative step change in the sustained delivery of drug molecules. The PANOPTES consortium's goal is to research and develop novel drug delivery technology for the posterior eye segment. This partnership further validates the innovative properties of DSM's polyesteramide (PEA) biomaterials as a superior drug delivery technology.
Participants are being enrolled in the first clinical trial that tests the use of retinal progenitor cells to treat retinitis pigmentosa, reported project director Dr. Henry Klassen of UCI's Gavin Herbert Eye Institute and Sue & Bill Gross Stem Cell Research Center. The product of stem cell research at UCI, these retinal progenitors are similar to stem cells in terms of potential regenerative properties, but they're specific to the retina.
› Verified 8 days ago
| Entity Name | Loyola University Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336159961 PECOS PAC ID: 3779488903 Enrollment ID: O20031202000027 |
News Archive
The discovery that a protein called Rictor plays a key role in destroying a close cousin of the AKT oncogene could provide scientists with a new molecular target for treating certain cancers, including breast cancer. Described in the September 2010 issue of the journal Molecular Cell, the study was led by scientists at Beth Israel Deaconess Medical Center (BIDMC).
A researcher from the Center for BrainHealth at UT Dallas has been awarded a $2.7 million grant from the Department of Defense under the Joint Warfighter Medical Research Program.
DSM, a global leader in biomedical materials sciences, today announced that it is contributing proprietary knowledge in the preparation of tailored amino acid-based polymers and offering use of processing facilities that will produce an innovative step change in the sustained delivery of drug molecules. The PANOPTES consortium's goal is to research and develop novel drug delivery technology for the posterior eye segment. This partnership further validates the innovative properties of DSM's polyesteramide (PEA) biomaterials as a superior drug delivery technology.
Participants are being enrolled in the first clinical trial that tests the use of retinal progenitor cells to treat retinitis pigmentosa, reported project director Dr. Henry Klassen of UCI's Gavin Herbert Eye Institute and Sue & Bill Gross Stem Cell Research Center. The product of stem cell research at UCI, these retinal progenitors are similar to stem cells in terms of potential regenerative properties, but they're specific to the retina.
› Verified 8 days ago
| Entity Name | Midwest Digestive Health & Nutrition, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477241750 PECOS PAC ID: 2769830389 Enrollment ID: O20231121000521 |
News Archive
The discovery that a protein called Rictor plays a key role in destroying a close cousin of the AKT oncogene could provide scientists with a new molecular target for treating certain cancers, including breast cancer. Described in the September 2010 issue of the journal Molecular Cell, the study was led by scientists at Beth Israel Deaconess Medical Center (BIDMC).
A researcher from the Center for BrainHealth at UT Dallas has been awarded a $2.7 million grant from the Department of Defense under the Joint Warfighter Medical Research Program.
DSM, a global leader in biomedical materials sciences, today announced that it is contributing proprietary knowledge in the preparation of tailored amino acid-based polymers and offering use of processing facilities that will produce an innovative step change in the sustained delivery of drug molecules. The PANOPTES consortium's goal is to research and develop novel drug delivery technology for the posterior eye segment. This partnership further validates the innovative properties of DSM's polyesteramide (PEA) biomaterials as a superior drug delivery technology.
Participants are being enrolled in the first clinical trial that tests the use of retinal progenitor cells to treat retinitis pigmentosa, reported project director Dr. Henry Klassen of UCI's Gavin Herbert Eye Institute and Sue & Bill Gross Stem Cell Research Center. The product of stem cell research at UCI, these retinal progenitors are similar to stem cells in terms of potential regenerative properties, but they're specific to the retina.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Zuie Wakade, 1400 S Michigan Ave Apt 1203, Chicago, IL 60605-3720 Ph: (312) 767-3244 | Dr Zuie Wakade, 900 Rand Rd Ste 120, Des Plaines, IL 60016-2359 Ph: (312) 767-3244 |
News Archive
The discovery that a protein called Rictor plays a key role in destroying a close cousin of the AKT oncogene could provide scientists with a new molecular target for treating certain cancers, including breast cancer. Described in the September 2010 issue of the journal Molecular Cell, the study was led by scientists at Beth Israel Deaconess Medical Center (BIDMC).
A researcher from the Center for BrainHealth at UT Dallas has been awarded a $2.7 million grant from the Department of Defense under the Joint Warfighter Medical Research Program.
DSM, a global leader in biomedical materials sciences, today announced that it is contributing proprietary knowledge in the preparation of tailored amino acid-based polymers and offering use of processing facilities that will produce an innovative step change in the sustained delivery of drug molecules. The PANOPTES consortium's goal is to research and develop novel drug delivery technology for the posterior eye segment. This partnership further validates the innovative properties of DSM's polyesteramide (PEA) biomaterials as a superior drug delivery technology.
Participants are being enrolled in the first clinical trial that tests the use of retinal progenitor cells to treat retinitis pigmentosa, reported project director Dr. Henry Klassen of UCI's Gavin Herbert Eye Institute and Sue & Bill Gross Stem Cell Research Center. The product of stem cell research at UCI, these retinal progenitors are similar to stem cells in terms of potential regenerative properties, but they're specific to the retina.
› Verified 8 days ago
Steven Hendler, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 900 Rand Rd Ste 120, Des Plaines, IL 60016 Phone: 312-767-3244 | |
Rajan H Patel, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 9301 Golf Rd, Suite 302, Des Plaines, IL 60016 Phone: 847-296-8151 Fax: 847-296-3915 | |
Bela D Desai, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 77 Rand Rd, Des Plaines, IL 60016 Phone: 847-803-1344 Fax: 847-803-3791 | |
Gary K Artinian, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 77 Rand Rd, Des Plaines, IL 60016 Phone: 847-298-0310 Fax: 847-298-5939 | |
Dr. Mukund Venu, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 900 Rand Rd Ste 120, Des Plaines, IL 60016 Phone: 312-767-3244 | |
Peter Werner, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 150 N River Rd, Suite 210, Des Plaines, IL 60016 Phone: 847-759-4060 Fax: 847-759-4066 |